Not Yet Recruiting EARLY_PHASE1 INTERVENTIONAL 2-arm
NCT07362992
Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery
Does Topical Use of Tranexamic Acid During a Cesarean Delivery Reduce Intra-surgical Bleeding? A Randomized ,Multi-center Trial
Sponsor: Kaplan Medical Center
Interventions
Normal Saline (Placebo) Tranexamic Acid (Topical)
Updated 1 time since 2026 Last updated: Jan 14, 2026 Started: Jan 1, 2026 Primary completion: Dec 1, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07362992, this EARLY_PHASE1 trial focuses on Cesarean Delivery and Hemostasis and remains actively recruiting participants. Sponsored by Kaplan Medical Center, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — EARLY_PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Kaplan Medical Center
- Meir Medical Center
- Rabin Medical Center
- Wolfson Medical Center
Data source: Wolfson Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .